mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.006 |
mRNA |
JQ-1:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.006 |
mRNA |
OSI-027 |
GDSC1000 |
pan-cancer |
AAC |
0.093 |
0.007 |
mRNA |
KHS101 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.007 |
mRNA |
Zebularine |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.007 |
mRNA |
AICAR |
GDSC1000 |
pan-cancer |
AAC |
0.094 |
0.007 |
mRNA |
Tipifarnib |
GDSC1000 |
pan-cancer |
AAC |
0.1 |
0.008 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.098 |
0.008 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.008 |
mRNA |
NPK76-II-72-1 |
GDSC1000 |
pan-cancer |
AAC |
0.085 |
0.009 |